SCHEMBL6593585

SCHEMBL6593585

O=C(O)c1cc(O)c2cc(-c3cccnc3)cc(OCc3ccccc3)c2n1

nearest known ligand 0.51

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
CYP11B1 P15538 6/20 0.47
CYP11B2 P19099 6/20 0.47
CYP19A1 P11511 4/20 0.47
MAPT P10636 1/20 0.44
PTPN1 P18031 1/20 0.43
MCL1 Q07820 1/20 0.43
IKBKB O14920 1/20 0.42
MAP4K4 O95819 1/20 0.42
PDPK1 O15530 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.41
SGMS2 Q8NHU3 1/20 0.41
SMPD1 P17405 2/20 0.41
LRRK2 Q5S007 1/20 0.41
KMO O15229 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6080624 0.90 CYP11B1 (0.48) CYP11B1CYP11B2CYP19A1MAPTPTPN1
SCHEMBL6080604 0.86 CYP11B1 (0.44) CYP11B1CYP11B2CYP19A1MAPTIKBKB
SCHEMBL6595828 0.84 MRGPRX4 (0.44) PTPN1MCL1MAP4K4KMO
SCHEMBL6594732 0.83 MCL1 (0.49) PTPN1MCL1MAP4K4
SCHEMBL6588409 0.82 MCL1 (0.46) PTPN1MCL1MAP4K4KMO
SCHEMBL6592298 0.82 MCL1 (0.53) MAPTPTPN1MCL1MAP4K4
SCHEMBL6080629 0.81 CYP11B1 (0.47) CYP11B1CYP11B2CYP19A1MAPTMCL1
SCHEMBL6080980 0.81 L3MBTL1 (0.53) CYP11B1CYP11B2CYP19A1L3MBTL1KMO
SCHEMBL6590308 0.80 MAPT (0.42) MAPTPTPN1MCL1MAP4K4
SCHEMBL6594866 0.79 PTGER1 (0.44) MAPTMCL1MAP4K4L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1451159-A1 COMPOSITIONS DERIVED FROM QUINOLINE AND QUINOXALINE, PREPARATION AND USE THEREOF NEURO3D (FR) 2004-09-01 EP claimed
WO-2003010146-A1 COMPOSITIONS DERIVED FROM QUINOLINE AND QUINOXALINE, PREPARATION AND USE THEREOF NEURO3D (FR) 2003-02-06 WO claimed
EP-1451159-A1 COMPOSITIONS DERIVED FROM QUINOLINE AND QUINOXALINE, PREPARATION AND USE THEREOF NEURO3D (FR) 2004-09-01 EP disclosed
WO-2003010146-A1 COMPOSITIONS DERIVED FROM QUINOLINE AND QUINOXALINE, PREPARATION AND USE THEREOF NEURO3D (FR) 2003-02-06 WO disclosed